本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Molecular Partners AG

4.00
+0.09002.30%
成交量:1.06万
成交额:4.24万
市值:1.47亿
市盈率:-2.28
高:4.25
开:4.16
低:3.87
收:3.91
数据加载中...
2025/03/06

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/10/29

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/11/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/01/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/14

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/06/14

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/06/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/10

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers